Improving HIV testing, linkage, and retention in care among South African men through U = U messaging: A study protocol for two sequential hybrid type 1 effectiveness-implementation randomized controlled trials

Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 19; no. 11; p. e0309905
Main Authors Medina-Marino, Andrew, Sibanda, Nkosiyapha, Putt, Mary, Joseph Davey, Dvora, Smith, Phillip, Thirumurthy, Harsha, Bekker, Linda-Gail, Buttenheim, Alison
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 25.11.2024
Public Library of Science (PLoS)
Subjects
Adult
Analysis
Anti-HIV Agents - therapeutic use
Antiretroviral drugs
Antiretroviral therapy
Antiviral agents
Biology and Life Sciences
Care and treatment
Clinics
Disease control
Dosage and administration
Effectiveness
Health aspects
Heterosexuality
HIV
HIV Infections - diagnosis
HIV Infections - drug therapy
HIV Infections - epidemiology
HIV Infections - psychology
HIV patients
HIV testing
HIV Testing - methods
Human immunodeficiency virus
Human subjects
Humans
Informed consent
Male
Mass Screening - methods
Medical record linkage
Medical tests
Medicine and Health Sciences
Men
Messages
Mortality risk
People and Places
Public health
Randomized Controlled Trials as Topic
Research ethics
Retention
Retention in Care
South Africa - epidemiology
Standard of care
Study Protocol
South Africa
Eastern Cape South Africa
Online AccessGet full text

Cover

Abstract Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings. Building on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa. These trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
AbstractList BackgroundIncreasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings.MethodsBuilding on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa.DiscussionThese trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
Background Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings. Methods Building on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men’s uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa. Discussion These trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings. Building on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa. These trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
Background Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings. Methods Building on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa. Discussion These trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings. Building on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa. These trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings.BACKGROUNDIncreasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to women, cis-gender heterosexual men living with HIV are significantly less likely to know their HIV status, initiate anti-retroviral therapy (ART) and achieve viral suppression. This is particularly true in South Africa, where men are also at increased risk of mortality resulting from AIDS-related illnesses. While there is growing knowledge of Treatment as Prevention or the concept Undetectable = Untransmittable (U = U) among PLHIV in Western and high-income countries, the reach and penetration of the U = U message in sub-Saharan Africa remains limited, and few studies have evaluated the impact of accessible and relatable U = U messages on ART initiation and adherence. To address these gaps, rigorous evaluations of interventions that incorporate U = U messages are needed, especially among men in high prevalence settings.Building on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa.METHODSBuilding on our U = U messages that we previously developed for men using behavioral economics insights and a human-centered design, we will conduct two sequential hybrid type 1 effectiveness-implementation trials to evaluate the impact of U = U messages on men's uptake of community-based HIV testing and ART initiation (Trial 1), and retention in care and achievement of viral suppression (Trial 2). For trial 1, a cluster randomized trial will be implemented with HIV testing service site-days (each day at one testing site) randomized to U = U or standard-of-care (SoC) messages inviting men to test for HIV. For trial 2, an individual-level randomized control trial will be implemented, with men initiating ART at six government clinics randomized to receive U = U counselling or SoC treatment adherence messaging. We will incorporate a multi-method evaluation to inform future implementation of U = U messaging interventions. The study will be conducted in the Buffalo City Metro Health District of the Eastern Cape Province and in the Cape Town Metro Health District in the Western Cape Province in South Africa.These trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.DISCUSSIONThese trials are the first to rigorously evaluate the impact of U = U messaging on HIV testing uptake, ART initiation and achievement of viral suppression among African men. If effective, these messaging interventions can shape global HIV testing, treatment and adherence counselling guidelines and practices.
Audience Academic
Author Smith, Phillip
Joseph Davey, Dvora
Putt, Mary
Bekker, Linda-Gail
Buttenheim, Alison
Sibanda, Nkosiyapha
Thirumurthy, Harsha
Medina-Marino, Andrew
AuthorAffiliation 6 Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States of America
1 Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
3 Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
5 Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States of America
7 Division of Epidemiology & Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
4 Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
Public Library of Science, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
9 Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA,
AuthorAffiliation_xml – name: 4 Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
– name: 8 Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America
– name: 2 Desmond Tutu Health Foundation, Cape Town, South Africa
– name: 5 Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States of America
– name: 6 Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, United States of America
– name: 9 Center for Health Incentives and Behavioral Economics, University of Pennsylvania, Philadelphia, PA, United States of America
– name: 10 Department of Family and Community Health, School of Nursing, University of Pennsylvania, Philadelphia PA, United States of America
– name: 1 Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
– name: 7 Division of Epidemiology & Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
– name: Public Library of Science, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND
– name: 3 Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
Author_xml – sequence: 1
  givenname: Andrew
  orcidid: 0000-0002-2691-982X
  surname: Medina-Marino
  fullname: Medina-Marino, Andrew
– sequence: 2
  givenname: Nkosiyapha
  surname: Sibanda
  fullname: Sibanda, Nkosiyapha
– sequence: 3
  givenname: Mary
  surname: Putt
  fullname: Putt, Mary
– sequence: 4
  givenname: Dvora
  surname: Joseph Davey
  fullname: Joseph Davey, Dvora
– sequence: 5
  givenname: Phillip
  surname: Smith
  fullname: Smith, Phillip
– sequence: 6
  givenname: Harsha
  surname: Thirumurthy
  fullname: Thirumurthy, Harsha
– sequence: 7
  givenname: Linda-Gail
  surname: Bekker
  fullname: Bekker, Linda-Gail
– sequence: 8
  givenname: Alison
  surname: Buttenheim
  fullname: Buttenheim, Alison
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39585844$$D View this record in MEDLINE/PubMed
BookMark eNqNk21rFDEQxxep2Af9BqIBQRR6Z572SRA5itqDQsHavg3Z7Oxe6m5yJtnT82P6icz2rqUnfSHLkmH2N_-ZzOwcJnvGGkiS5wRPCcvJu2s7OCO76TK6p5jhssTpo-SAlIxOMorZ3j17Pzn0_hrjlBVZ9iTZZ2VapAXnB8mfeb90dqVNi07nVyiAD9E-Rp0232ULx0iaGjkIYIK2BmmDlHSAZG9jxIUdwgLNGqeVNKgHg8LC2aFdoEv0Ib49eC_bqPcezZAPQ71GMVmwynaosQ6FnxZ5-DGM4rJDi3XldI3CegmIIGgaUEGvwESVie6XHcQMQd7U4WJZtte_oUbKmuBs10UzuCjjnyaPm3jAs-15lFx-_vTt5HRydv5lfjI7m6iM0zBJ87xilGDgOKesgSarpaQlZTxPCVOUKkmBEJxRmjaV5FzKgvFMViktSE0kO0pebnSXnfViOw4vGGE0z9MyKyMx3xC1lddi6XQv3VpYqcWNw7pWSBe06kDUuOLAJaaKK04wi-EpUVlVsaaGhoxaH7fZhqqHWsVWONntiO5-MXohWrsShKRFQdNR4c1WwdnYcx9Er72CrpMG7LApvOCkzLKIvvoHffh6W6qV8QbaNDYmVqOomBUkz_KSYhqp6QNUfGrodRweNDr6dwLe7gSMA4ZfoZWD92J-8fX_2fOrXfb1PXYBsgsLb7th_KH8Lvjifqvveny7NRHgG0A5672D5g4hWIzLedsuMS6n2C4n-wu-By6q
Cites_doi 10.1016/S0140-6736(23)00877-2
10.7448/IAS.19.1.21106
10.1001/jama.2016.5148
10.5888/pcd15.170271
10.1007/s10488-020-01052-z
10.1089/apc.2021.0101
10.1186/1748-5908-4-50
10.1038/s41467-019-13473-y
10.1007/s10461-020-02849-7
10.1371/journal.pone.0157339
10.1186/s12889-023-15306-6
10.1002/jia2.25529
10.1177/0963721416689563
10.1371/journal.pone.0186744
10.1371/journal.pone.0080017
10.3389/frhs.2022.1053496
10.1016/j.jretconser.2015.12.001
10.1097/QAI.0b013e3181f275fd
10.2196/humanfactors.5443
10.2105/AJPH.2010.197608
10.1007/s10461-019-02531-7
10.1097/MLR.0b013e3182408812
10.1371/journal.pone.0103205
10.1007/s10461-019-02405-y
10.1002/jia2.25466
10.1037/0278-6133.14.2.141
10.1097/QAI.0000000000002216
10.1016/S0140-6736(19)30418-0
10.3389/fpubh.2019.00064
10.9745/GHSP-D-20-00078
10.1097/COH.0000000000000396
10.1002/jia2.25968
10.1093/ije/dyz237
10.1016/j.amepre.2014.10.014
10.1016/S2352-3018(19)30030-X
10.1146/annurev-publhealth-031912-114353
10.1371/journal.pmed.1001905
10.1097/QAI.0000000000002239
10.1080/09540121.2019.1653438
10.7196/SAMJ.4162
10.1007/s10461-021-03284-y
10.1001/jamapsychiatry.2021.1120
10.1097/QAI.0000000000001637
10.1016/S0140-6736(23)01519-2
10.1186/s13063-021-05402-6
10.1007/s10461-016-1306-0
10.1111/tmi.12301
10.1007/s10461-021-03296-8
10.1002/jia2.25530
10.7448/IAS.18.1.20039
10.1002/jia2.25678
10.1007/s10461-019-02603-8
10.1056/NEJMoa1600693
10.1016/S2352-3018(18)30132-2
10.1371/journal.pmed.1001304
10.1007/s10461-014-0959-9
10.1007/s10742-008-0028-9
10.1371/journal.pone.0145847
10.1097/QAI.0000000000001557
10.1001/jama.2018.21167
10.1093/ije/dyz269
10.4102/sajhivmed.v18i1.694
10.1186/s13012-022-01245-0
ContentType Journal Article
Copyright Copyright: © 2024 Medina-Marino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
COPYRIGHT 2024 Public Library of Science
2024 Medina-Marino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 Medina-Marino et al 2024 Medina-Marino et al
2024 Medina-Marino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright: © 2024 Medina-Marino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
– notice: COPYRIGHT 2024 Public Library of Science
– notice: 2024 Medina-Marino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 Medina-Marino et al 2024 Medina-Marino et al
– notice: 2024 Medina-Marino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0309905
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
ProQuest Biological Science Collection
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database ProQuest
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE



MEDLINE - Academic
Agricultural Science Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Public Health
DocumentTitleAlternate U = U messaging to improve men’s engagement in HIV services
EISSN 1932-6203
ExternalDocumentID 3132775969
oai_doaj_org_article_d0b4e4a02c4c410396951c6bb3fdef19
PMC11588259
A817679202
39585844
10_1371_journal_pone_0309905
Genre Clinical Trial Protocol
Journal Article
GeographicLocations South Africa
Eastern Cape South Africa
GeographicLocations_xml – name: South Africa
– name: Eastern Cape South Africa
GrantInformation_xml – fundername: FIC NIH HHS
  grantid: D43 TW012497
– fundername: NIMH NIH HHS
  grantid: R01 MH129223
– fundername: ;
  grantid: R01MH129223
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
ADRAZ
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c642t-577b3210e40723fef6daa292347513c22ca2e1106225fba44aa8346ab5281d1a3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Wed Aug 13 01:18:24 EDT 2025
Wed Aug 27 01:30:49 EDT 2025
Thu Aug 21 18:32:20 EDT 2025
Fri Jul 11 12:30:01 EDT 2025
Fri Jul 25 11:19:21 EDT 2025
Tue Jun 17 21:56:06 EDT 2025
Tue Jun 10 20:54:19 EDT 2025
Fri Jun 27 05:14:24 EDT 2025
Fri Jun 27 05:14:11 EDT 2025
Thu May 22 21:23:28 EDT 2025
Thu Apr 03 07:00:58 EDT 2025
Tue Jul 01 02:56:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License Copyright: © 2024 Medina-Marino et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c642t-577b3210e40723fef6daa292347513c22ca2e1106225fba44aa8346ab5281d1a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Undefined-1
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-2691-982X
OpenAccessLink https://doaj.org/article/d0b4e4a02c4c410396951c6bb3fdef19
PMID 39585844
PQID 3132775969
PQPubID 1436336
PageCount e0309905
ParticipantIDs plos_journals_3132775969
doaj_primary_oai_doaj_org_article_d0b4e4a02c4c410396951c6bb3fdef19
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11588259
proquest_miscellaneous_3132841966
proquest_journals_3132775969
gale_infotracmisc_A817679202
gale_infotracacademiconefile_A817679202
gale_incontextgauss_ISR_A817679202
gale_incontextgauss_IOV_A817679202
gale_healthsolutions_A817679202
pubmed_primary_39585844
crossref_primary_10_1371_journal_pone_0309905
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-11-25
PublicationDateYYYYMMDD 2024-11-25
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-25
  day: 25
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2024
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References GM Curran (pone.0309905.ref051) 2012; 50
AN Bazzano (pone.0309905.ref030) 2017; 12
SK Calabrese (pone.0309905.ref034) 2019; 6
M Cornell (pone.0309905.ref009) 2012; 9
RW Eisinger (pone.0309905.ref020) 2019; 321
K Kranzer (pone.0309905.ref012) 2010; 55
National Department of Health. (pone.0309905.ref068) 2016
pone.0309905.ref023
pone.0309905.ref067
South African National Department of Health. (pone.0309905.ref062) 2016
M Osler (pone.0309905.ref010) 2020; 2
G Prati (pone.0309905.ref044) 2016; 11
A Stein (pone.0309905.ref064) 2016; 30
KG Lynch (pone.0309905.ref066) 2008; 8
AJ Rodger (pone.0309905.ref015) 2016; 316
RE Glasgow (pone.0309905.ref071) 2018; 15
LJ Damschroder (pone.0309905.ref073) 2022; 17
R Harte (pone.0309905.ref028) 2017; 4
JD Brewer (pone.0309905.ref077) 2020; 8
P Smith (pone.0309905.ref061) 2021; 25
MM Paschen-Wolff (pone.0309905.ref039) 2020; 24
LF Johnson (pone.0309905.ref053) 2017; 18
DJ Davey (pone.0309905.ref011) 2020; 23
PJ Smith (pone.0309905.ref060) 2023; 23
KG Card (pone.0309905.ref036) 2018; 77
T. Rice (pone.0309905.ref025) 2013; 34
RE Glasgow (pone.0309905.ref072) 2019; 77
K Siegel (pone.0309905.ref035) 2019; 23
pone.0309905.ref054
N van Schaik (pone.0309905.ref056) 2010; 100
C Catalani (pone.0309905.ref027) 2014; 9
G Nakigozi (pone.0309905.ref006) 2020
pone.0309905.ref019
GO Matheson (pone.0309905.ref031) 2015; 48
PJ Smith (pone.0309905.ref032) 2021; 35
AJ Rodger (pone.0309905.ref018) 2019; 393
HJ Rendina (pone.0309905.ref038) 2020; 83
A Medina-Marino (pone.0309905.ref055) 2022; 25
DK King (pone.0309905.ref070) 2020; 8
J Bor (pone.0309905.ref008) 2015; 12
pone.0309905.ref080
MG Millar (pone.0309905.ref024) 1995; 14
K Ngure (pone.0309905.ref040) 2020; 23
C Mandimika (pone.0309905.ref075) 2023
RE Stewart (pone.0309905.ref078) 2021; 48
pone.0309905.ref042
pone.0309905.ref001
pone.0309905.ref002
A Vandormael (pone.0309905.ref004) 2020; 49
pone.0309905.ref003
LK Beres (pone.0309905.ref029) 2019; 3
A Medina-Marino (pone.0309905.ref058); 24
LN Broyles (pone.0309905.ref021) 2023; 402
J Arndt (pone.0309905.ref026) 2017; 26
MS Cohen (pone.0309905.ref016) 2016; 375
J. Swain (pone.0309905.ref076) 2018
A Vandormael (pone.0309905.ref005) 2019; 10
BR Bavinton (pone.0309905.ref017) 2018; 5
SC Kalichman (pone.0309905.ref049) 2011; 101
D Govindasamy (pone.0309905.ref057) 2013; 8
J Pulerwitz (pone.0309905.ref007) 2019; 23
M Holt (pone.0309905.ref041) 2016; 20
GM Curran (pone.0309905.ref052) 2022; 2
LG Bekker (pone.0309905.ref022) 2023; 402
CE Newman (pone.0309905.ref046) 2015; 19
SC Kalichman (pone.0309905.ref050) 2018; 78
C Couffignal (pone.0309905.ref045); 32
LJ Damschroder (pone.0309905.ref069) 2009; 4
BR Bavinton (pone.0309905.ref047) 2016; 11
K Hemming (pone.0309905.ref063) 2020; 49
SW Beckham (pone.0309905.ref013) 2016; 19
M Plazy (pone.0309905.ref014) 2014; 19
pone.0309905.ref033
RS Beidas (pone.0309905.ref074) 2021; 78
pone.0309905.ref079
JA Bauermeister (pone.0309905.ref065) 2017; 12
J Bor (pone.0309905.ref048) 2021; 25
A Ndyabakira (pone.0309905.ref043) 2020; 24
A Carter (pone.0309905.ref037) 2015; 18
A Medina-Marino (pone.0309905.ref059) 2021; 22
37886512 - Res Sq. 2023 Oct 04:rs.3.rs-3349696. doi: 10.21203/rs.3.rs-3349696/v1.
References_xml – ident: pone.0309905.ref001
– volume: 402
  start-page: 464
  issue: 10400
  year: 2023
  ident: pone.0309905.ref021
  article-title: The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review
  publication-title: Lancet
  doi: 10.1016/S0140-6736(23)00877-2
– volume: 19
  start-page: 21106
  issue: 1
  year: 2016
  ident: pone.0309905.ref013
  article-title: Marked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis.
  publication-title: J Int AIDS Soc
  doi: 10.7448/IAS.19.1.21106
– volume: 316
  start-page: 171
  issue: 2
  year: 2016
  ident: pone.0309905.ref015
  article-title: Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
  publication-title: JAMA
  doi: 10.1001/jama.2016.5148
– volume: 15
  start-page: E02
  year: 2018
  ident: pone.0309905.ref071
  article-title: Pragmatic Applications of RE-AIM for Health Care Initiatives in Community and Clinical Settings.
  publication-title: Prev Chronic Dis.
  doi: 10.5888/pcd15.170271
– volume: 48
  start-page: 131
  issue: 1
  year: 2021
  ident: pone.0309905.ref078
  article-title: Applying NUDGE to Inform Design of EBP Implementation Strategies in Community Mental Health Settings.
  publication-title: Adm Policy Ment Health.
  doi: 10.1007/s10488-020-01052-z
– volume: 35
  start-page: 428
  issue: 11
  year: 2021
  ident: pone.0309905.ref032
  article-title: Participatory Prototyping of a Tailored Undetectable Equals Untransmittable Message to Increase HIV Testing Among Men in Western Cape, South Africa.
  publication-title: AIDS Patient Care STDS
  doi: 10.1089/apc.2021.0101
– volume: 4
  start-page: 50
  year: 2009
  ident: pone.0309905.ref069
  article-title: Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.
  publication-title: Implement Sci
  doi: 10.1186/1748-5908-4-50
– volume: 10
  start-page: 5482
  issue: 1
  year: 2019
  ident: pone.0309905.ref005
  article-title: Declines in HIV incidence among men and women in a South African population-based cohort.
  publication-title: Nat Commun.
  doi: 10.1038/s41467-019-13473-y
– volume: 24
  start-page: 2984
  issue: 10
  year: 2020
  ident: pone.0309905.ref039
  article-title: HIV Treatment Knowledge in the Context of “Treatment as Prevention” (TasP).
  publication-title: AIDS Behav
  doi: 10.1007/s10461-020-02849-7
– year: 2016
  ident: pone.0309905.ref062
  article-title: HIV Testing Services: Policy 2016
  publication-title: Pretoria, South Africa;
– volume: 11
  start-page: e0157339
  issue: 6
  year: 2016
  ident: pone.0309905.ref044
  article-title: PEP and TasP Awareness among Italian MSM, PLWHA, and High-Risk Heterosexuals and Demographic, Behavioral, and Social Correlates.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0157339
– volume: 23
  start-page: 418
  issue: 1
  year: 2023
  ident: pone.0309905.ref060
  article-title: What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa.
  publication-title: BMC Public Health.
  doi: 10.1186/s12889-023-15306-6
– volume: 23
  start-page: e25529
  issue: 6
  year: 2020
  ident: pone.0309905.ref011
  article-title: Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
  publication-title: J Int AIDS Soc
  doi: 10.1002/jia2.25529
– volume: 26
  start-page: 126
  issue: 2
  year: 2017
  ident: pone.0309905.ref026
  article-title: Where Health and Death Intersect: Insights from a Terror Management Health Model.
  publication-title: Curr Dir Psychol Sci.
  doi: 10.1177/0963721416689563
– volume: 12
  start-page: e0186744
  issue: 11
  year: 2017
  ident: pone.0309905.ref030
  article-title: Human-centred design in global health: A scoping review of applications and contexts.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0186744
– volume: 8
  start-page: e80017
  issue: 11
  year: 2013
  ident: pone.0309905.ref057
  article-title: Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0080017
– volume: 2
  start-page: 1053496
  year: 2022
  ident: pone.0309905.ref052
  article-title: Reflections on 10 years of effectiveness-implementation hybrid studies.
  publication-title: Front Health Serv.
  doi: 10.3389/frhs.2022.1053496
– volume: 30
  start-page: 8
  year: 2016
  ident: pone.0309905.ref064
  article-title: Towards the identification of customer experience touch point elements
  publication-title: Journal of Retailing and Consumer Services
  doi: 10.1016/j.jretconser.2015.12.001
– volume: 55
  start-page: e17
  issue: 3
  year: 2010
  ident: pone.0309905.ref012
  article-title: Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors.
  publication-title: J Acquir Immune Defic Syndr.
  doi: 10.1097/QAI.0b013e3181f275fd
– ident: pone.0309905.ref067
– volume: 4
  start-page: e8
  issue: 1
  year: 2017
  ident: pone.0309905.ref028
  article-title: A Human-Centered Design Methodology to Enhance the Usability, Human Factors, and User Experience of Connected Health Systems: A Three-Phase Methodology.
  publication-title: JMIR Hum Factors.
  doi: 10.2196/humanfactors.5443
– volume: 101
  start-page: 531
  issue: 3
  year: 2011
  ident: pone.0309905.ref049
  article-title: Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission.
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.2010.197608
– volume: 24
  start-page: 967
  issue: 3
  year: 2020
  ident: pone.0309905.ref043
  article-title: Men’s Beliefs About the Likelihood of Serodiscordance in Couples with an HIV-Positive Partner: Survey Evidence from Rural Uganda
  publication-title: AIDS Behav
  doi: 10.1007/s10461-019-02531-7
– volume: 50
  start-page: 217
  issue: 3
  year: 2012
  ident: pone.0309905.ref051
  article-title: Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.
  publication-title: Med Care.
  doi: 10.1097/MLR.0b013e3182408812
– volume: 9
  start-page: e103205
  issue: 8
  year: 2014
  ident: pone.0309905.ref027
  article-title: A clinical decision support system for integrating tuberculosis and HIV care in Kenya: a human-centered design approach.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0103205
– volume: 23
  start-page: 1974
  issue: 7
  year: 2019
  ident: pone.0309905.ref035
  article-title: Awareness and Perceived Effectiveness of HIV Treatment as Prevention Among Men Who Have Sex with Men in New York City
  publication-title: AIDS Behav
  doi: 10.1007/s10461-019-02405-y
– volume: 23
  start-page: e25466
  issue: 3
  year: 2020
  ident: pone.0309905.ref040
  article-title: “I just believe there is a risk” understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya.
  publication-title: J Int AIDS Soc
  doi: 10.1002/jia2.25466
– volume: 14
  start-page: 141
  issue: 2
  year: 1995
  ident: pone.0309905.ref024
  article-title: Negative affective consequences of thinking about disease detection behaviors.
  publication-title: Health Psychol.
  doi: 10.1037/0278-6133.14.2.141
– volume: 3
  start-page: S230
  issue: 3
  year: 2019
  ident: pone.0309905.ref029
  article-title: Human-Centered Design Lessons for Implementation Science: Improving the Implementation of a Patient-Centered Care Intervention.
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000002216
– volume-title: Adherence Guidelines for HIV, TB and NCDs
  year: 2016
  ident: pone.0309905.ref068
– volume: 393
  start-page: 2428
  issue: 10189
  year: 2019
  ident: pone.0309905.ref018
  article-title: Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)30418-0
– volume: 77
  start-page: 64
  issue: 64
  year: 2019
  ident: pone.0309905.ref072
  article-title: RE-AIM Planning and Evaluation Framework: Adapting to New Science and Practice With a 20-Year Review.
  publication-title: Front Public Health.
  doi: 10.3389/fpubh.2019.00064
– volume: 8
  start-page: 721
  issue: 4
  year: 2020
  ident: pone.0309905.ref077
  article-title: Behavioral Insights Into Micronutrient Powder Use for Childhood Anemia in Arequipa, Peru.
  publication-title: Glob Health Sci Pract.
  doi: 10.9745/GHSP-D-20-00078
– volume: 12
  start-page: 442
  issue: 5
  year: 2017
  ident: pone.0309905.ref065
  article-title: Addressing engagement in technology-based behavioural HIV interventions through paradata metrics
  publication-title: Curr Opin HIV AIDS
  doi: 10.1097/COH.0000000000000396
– year: 2018
  ident: pone.0309905.ref076
  publication-title: A Hybrid Approach to Thematic Analysis in Qualitative Research: Using a Practical Example
– volume: 25
  start-page: e25968
  issue: 7
  year: 2022
  ident: pone.0309905.ref055
  article-title: Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa.
  publication-title: J Int AIDS Soc
  doi: 10.1002/jia2.25968
– volume: 49
  start-page: 979
  issue: 3
  year: 2020
  ident: pone.0309905.ref063
  article-title: A tutorial on sample size calculation for multiple-period cluster randomized parallel, cross-over and stepped-wedge trials using the Shiny CRT Calculator.
  publication-title: Int J Epidemiol.
  doi: 10.1093/ije/dyz237
– volume: 48
  start-page: 472
  issue: 4
  year: 2015
  ident: pone.0309905.ref031
  article-title: Leveraging human-centered design in chronic disease prevention.
  publication-title: Am J Prev Med
  doi: 10.1016/j.amepre.2014.10.014
– volume: 6
  start-page: e211
  issue: 4
  year: 2019
  ident: pone.0309905.ref034
  article-title: Providers should discuss U = U with all patients living with HIV
  publication-title: Lancet HIV
  doi: 10.1016/S2352-3018(19)30030-X
– volume: 34
  start-page: 431
  year: 2013
  ident: pone.0309905.ref025
  article-title: The behavioral economics of health and health care
  publication-title: Annu Rev Public Health
  doi: 10.1146/annurev-publhealth-031912-114353
– volume: 12
  start-page: e1001905
  issue: 11
  year: 2015
  ident: pone.0309905.ref008
  article-title: Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa.
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1001905
– year: 2023
  ident: pone.0309905.ref075
  article-title: The NUDGE Handbook: A practical guide to behavioural design based on the NUDGE framework.
  publication-title: Version 2.
– volume: 83
  start-page: 215
  issue: 3
  year: 2020
  ident: pone.0309905.ref038
  article-title: Growing Acceptability of Undetectable = Untransmittable but Widespread Misunderstanding of Transmission Risk: Findings From a Very Large Sample of Sexual Minority Men in the United States.
  publication-title: J Acquir Immune Defic Syndr.
  doi: 10.1097/QAI.0000000000002239
– ident: pone.0309905.ref003
– year: 2020
  ident: pone.0309905.ref006
  article-title: Rapidly declining HIV incidence among men and women in Rakai, Uganda.
  publication-title: Conference on Retroviruses and Opportunistic Infections (CROI);
– volume: 32
  start-page: 811
  issue: 7
  ident: pone.0309905.ref045
  article-title: Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris.
  publication-title: AIDS Care
  doi: 10.1080/09540121.2019.1653438
– volume: 100
  start-page: 671
  issue: 10
  year: 2010
  ident: pone.0309905.ref056
  article-title: Earlier HIV diagnosis—are mobile services the answer?
  publication-title: S Afr Med J
  doi: 10.7196/SAMJ.4162
– volume: 25
  start-page: 3128
  issue: 10
  year: 2021
  ident: pone.0309905.ref061
  article-title: Undetectable  =  Untransmittable (U  =  U) Messaging Increases Uptake of HIV Testing Among Men: Results from a Pilot Cluster Randomized Trial.
  publication-title: AIDS Behav
  doi: 10.1007/s10461-021-03284-y
– volume: 78
  start-page: 941
  issue: 9
  year: 2021
  ident: pone.0309905.ref074
  article-title: Transforming Mental Health Care Delivery Through Implementation Science and Behavioral Economics.
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2021.1120
– volume: 78
  start-page: 34
  issue: 1
  year: 2018
  ident: pone.0309905.ref050
  article-title: Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).
  publication-title: J Acquir Immune Defic Syndr.
  doi: 10.1097/QAI.0000000000001637
– volume: 402
  start-page: 428
  issue: 10400
  year: 2023
  ident: pone.0309905.ref022
  article-title: HIV is sexually untransmittable when viral load is undetectable
  publication-title: Lancet
  doi: 10.1016/S0140-6736(23)01519-2
– volume: 22
  start-page: 489
  issue: 1
  year: 2021
  ident: pone.0309905.ref059
  article-title: The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
  publication-title: Trials.
  doi: 10.1186/s13063-021-05402-6
– volume: 20
  start-page: 1564
  issue: 7
  year: 2016
  ident: pone.0309905.ref041
  article-title: Increasing Belief in the Effectiveness of HIV Treatment as Prevention: Results of Repeated, National Surveys of Australian Gay and Bisexual Men, 2013–15
  publication-title: AIDS Behav
  doi: 10.1007/s10461-016-1306-0
– ident: pone.0309905.ref042
– volume: 19
  start-page: 680
  issue: 6
  year: 2014
  ident: pone.0309905.ref014
  article-title: Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal
  publication-title: South Africa. Trop Med Int Health
  doi: 10.1111/tmi.12301
– volume: 8
  issue: 59
  year: 2020
  ident: pone.0309905.ref070
  article-title: Planning for Implementation Success Using RE-AIM and CFIR Frameworks: A Qualitative Study.
  publication-title: Front Public Health.
– volume: 25
  start-page: 4209
  issue: 12
  year: 2021
  ident: pone.0309905.ref048
  article-title: Changing Knowledge and Attitudes Towards HIV Treatment-as-Prevention and “Undetectable  =  Untransmittable”: A Systematic Review.
  publication-title: AIDS Behav
  doi: 10.1007/s10461-021-03296-8
– ident: pone.0309905.ref080
– ident: pone.0309905.ref002
– volume: 2
  start-page: e25530
  year: 2020
  ident: pone.0309905.ref010
  article-title: Population-wide differentials in HIV service access and outcomes in the Western Cape for men as compared to women, South Africa: 2008 to 2018: a cohort analysis.
  publication-title: J Int AIDS Soc
  doi: 10.1002/jia2.25530
– volume: 18
  start-page: 20039
  issue: 1
  year: 2015
  ident: pone.0309905.ref037
  article-title: Gay and bisexual men’s awareness and knowledge of treatment as prevention: findings from the Momentum Health Study in Vancouver, Canada.
  publication-title: J Int AIDS Soc
  doi: 10.7448/IAS.18.1.20039
– volume: 24
  start-page: e25678
  issue: 3
  ident: pone.0309905.ref058
  article-title: Outcomes from a multimodal, at-scale community-based HIV counselling and testing programme in twelve high HIV burden districts in South Africa
  publication-title: J Int AIDS Soc
  doi: 10.1002/jia2.25678
– volume: 23
  start-page: 162
  issue: Suppl 2
  year: 2019
  ident: pone.0309905.ref007
  article-title: Gender Norms and HIV Testing/Treatment Uptake: Evidence from a Large Population-Based Sample in South Africa
  publication-title: AIDS Behav
  doi: 10.1007/s10461-019-02603-8
– ident: pone.0309905.ref023
– volume: 375
  start-page: 830
  issue: 9
  year: 2016
  ident: pone.0309905.ref016
  article-title: Antiretroviral Therapy for the Prevention of HIV-1 Transmission
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1600693
– volume: 5
  start-page: e438
  issue: 8
  year: 2018
  ident: pone.0309905.ref017
  article-title: Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
  publication-title: Lancet HIV
  doi: 10.1016/S2352-3018(18)30132-2
– ident: pone.0309905.ref019
– volume: 9
  start-page: e1001304
  issue: 9
  year: 2012
  ident: pone.0309905.ref009
  article-title: Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1001304
– ident: pone.0309905.ref033
– ident: pone.0309905.ref079
– volume: 19
  start-page: 821
  issue: 5
  year: 2015
  ident: pone.0309905.ref046
  article-title: Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy
  publication-title: AIDS Behav
  doi: 10.1007/s10461-014-0959-9
– volume: 8
  start-page: 57
  issue: 2
  year: 2008
  ident: pone.0309905.ref066
  article-title: Causal Mediation Analyses for Randomized Trials.
  publication-title: Health Serv Outcomes Res Methodol.
  doi: 10.1007/s10742-008-0028-9
– ident: pone.0309905.ref054
– volume: 11
  start-page: e0145847
  issue: 1
  year: 2016
  ident: pone.0309905.ref047
  article-title: Willingness to Act upon Beliefs about “Treatment as Prevention” among Australian Gay and Bisexual Men.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0145847
– volume: 77
  start-page: 8
  issue: 1
  year: 2018
  ident: pone.0309905.ref036
  article-title: Belief in Treatment as Prevention and Its Relationship to HIV Status and Behavioral Risk.
  publication-title: J Acquir Immune Defic Syndr.
  doi: 10.1097/QAI.0000000000001557
– volume: 321
  start-page: 451
  issue: 5
  year: 2019
  ident: pone.0309905.ref020
  article-title: HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable
  publication-title: JAMA
  doi: 10.1001/jama.2018.21167
– volume: 49
  start-page: 666
  issue: 2
  year: 2020
  ident: pone.0309905.ref004
  article-title: The state of the HIV epidemic in rural KwaZulu-Natal, South Africa: a novel application of disease metrics to assess trajectories and highlight areas for intervention.
  publication-title: Int J Epidemiol.
  doi: 10.1093/ije/dyz269
– volume: 18
  start-page: 694
  issue: 1
  year: 2017
  ident: pone.0309905.ref053
  article-title: Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa.
  publication-title: South Afr J HIV Med.
  doi: 10.4102/sajhivmed.v18i1.694
– volume: 17
  start-page: 75
  issue: 1
  year: 2022
  ident: pone.0309905.ref073
  article-title: The updated Consolidated Framework for Implementation Research based on user feedback.
  publication-title: Implement Sci.
  doi: 10.1186/s13012-022-01245-0
– reference: 37886512 - Res Sq. 2023 Oct 04:rs.3.rs-3349696. doi: 10.21203/rs.3.rs-3349696/v1.
SSID ssj0053866
Score 2.462412
Snippet Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However, compared to...
Background Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However,...
BackgroundIncreasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However,...
Background Increasing HIV testing and treatment coverage among people living with HIV (PLHIV) is essential for achieving global HIV epidemic control. However,...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e0309905
SubjectTerms Adult
Analysis
Anti-HIV Agents - therapeutic use
Antiretroviral drugs
Antiretroviral therapy
Antiviral agents
Biology and Life Sciences
Care and treatment
Clinics
Disease control
Dosage and administration
Effectiveness
Health aspects
Heterosexuality
HIV
HIV Infections - diagnosis
HIV Infections - drug therapy
HIV Infections - epidemiology
HIV Infections - psychology
HIV patients
HIV testing
HIV Testing - methods
Human immunodeficiency virus
Human subjects
Humans
Informed consent
Male
Mass Screening - methods
Medical record linkage
Medical tests
Medicine and Health Sciences
Men
Messages
Mortality risk
People and Places
Public health
Randomized Controlled Trials as Topic
Research ethics
Retention
Retention in Care
South Africa - epidemiology
Standard of care
Study Protocol
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZQn3hBjF8LG3AgJEBatsRxnBSJh4KYNiRAAjrtLXIcZ6vUJtXSCsGfyV_Ene1GDZoEDzxUiuprlfg-n-_iu-8Yez5OtZax4qGqahkKxFCo8hhDlaoqFdeV4BEVJ3_8JE-m4sN5er7V6otywhw9sJu4oyoqhREq4lpoQeeWEn0CLcsyqStTW8JPjnveJphyNhhXsZS-UC7J4iOvl8Nl25hDOlQYU7u6rY3I8vX3Vnm0nLfddS7nn5mTW1vR8W12y_uQMHH3vsNumOYO2_GrtIOXnkr61V32q39nACenZ7AiSo3m4gDo2BYNyQGopoIr8ptJPzBrgDLBwHYgAttdD1wjoQYWpgHf1Aem8AY_C-qeQj2OXsMELE0tEOtDi9ACdIVh9b0Fl6mNVmQOlz-oOAzonS_E4PJIvKkNZ4tNGru9D9w_q3Yx-2kq8Kn0c7y0DUa6e2x6_P7bu5PQd3EINcY2qzDNspIKhQxRsSW1qWWlFEe_UmRpnGjOteIGnRCJlqUulRBK5YmQqkw5-tKxSu6zUYN622WgjULvT_BaiVikKsPdtY6UyXUWVcZEccDCjUqLpSPrKOyJXYZBjtNNQRAoPAQC9pb03ssS1bb9AgFYeAAWfwNgwJ4QagpXt9objGKSx5nMxjziAXtmJYhuo6F8ngu17rri9PPZPwh9_TIQeuGF6hbxp5WvocBnIhqvgeT-QBKNhh4M7xLGN7PSFcTgmWUpPhz-coP764ef9sP0p5Sj15h27WRygRZdBuyBWyb9zCZjDEtzIQKWDxbQYOqHI83s0rKdY8iCUWA6fvg_lLXHbuLTCyom5ek-G62u1uYRepWr8rE1IL8BO2J5lw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ti9NAEF60fhHk8M6Xi546iqDC5S7ZbDaJIFLFoyeooPbot7DZbHqFNqlNi-jP9Bc5k2zjRQ7xQyF0JyHZedmZ3ZlnGHuahFpLX3FX5YV0BcqQq2IfQ5U8zxTXueAeFSd_-ChHY_F-Ek7shltt0yq3NrEx1HmlaY_8mCAGoyhMZPJ6-c2lrlF0umpbaFxl1wi6jFK6okkXcKEuS2nL5YLIP7bcOVpWpTmio4WEmtZdWI4a1P7ONg-W86q-zPH8O3_ywoJ0cpPtWE8Shi3rd9kVU-6xG-02HLTVRXts1-puDc8twPSLW-xXt5MAo9MzWBPQRjk9BDrMRfNyCKrMYUXeNHENZiVQfhg0fYmg6bkHbXuhEhamBNvqB8bwCn8L6qlCnY9ewhAa8FogLIgKBQ7QQYb19wra_G20LXM4_0ElY0A7weBDm11iDbA7W2yT25v3wFU1rxaznyYHm2A_x8um7Uh9m41P3n19O3JtbwdXY8SzdsMoyqh8yBBAW1CYQuZKcfQ2RRT6geZcK27QNZFob4pMCaFUHAipspCjh-2r4A4blMjHfQbaKPQJBS-U8EWoIlxzC0-ZWEdeboznO8zdsjhdthAeaXOOF2Ho0_IqJZFIrUg47A3JQUdLANzNH9Vqmlp9TnMvE0Yoj2uhBR2nS3RVtcyyoMhN4ScOe0RSlLbVrJ0ZSYexH8ko4R532JOGgkA4SsrymapNXaenn87-g-jL5x7RM0tUVCiPWtnKCvwmAvfqUR70KNGU6N7wPsn8dlbq9I_S4Z1bPbh8-HE3TA-lzL3SVJuWJhZo56XD7rZq081sgCqLDrBwWNxTqN7U90fK2XmDgY6BDMaGYXLv3-91n13H7xJUPMrDAzZYrzbmAXqR6-xhYyp-A__gdcU
  priority: 102
  providerName: ProQuest
Title Improving HIV testing, linkage, and retention in care among South African men through U = U messaging: A study protocol for two sequential hybrid type 1 effectiveness-implementation randomized controlled trials
URI https://www.ncbi.nlm.nih.gov/pubmed/39585844
https://www.proquest.com/docview/3132775969
https://www.proquest.com/docview/3132841966
https://pubmed.ncbi.nlm.nih.gov/PMC11588259
https://doaj.org/article/d0b4e4a02c4c410396951c6bb3fdef19
http://dx.doi.org/10.1371/journal.pone.0309905
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fb9MwELdG98ILYvxbYZQDIQHSMiWOE6dIE-qmjQ1pAw067S1yHGer1Caj6QTjY_KJuHPciKAheGhU1Zeose_Od7673zH2chhpHQeKeyovYk8gD3kqCdBVyfNMcZ0L7lNx8tFxfDAWH86isxW27NnqJrC-0bWjflLj-XTr-9frdyjw27ZrgwyWN21dVqXZopDBkEBNV3FvkiSqR6KNK6B02-glWS1ezP3QFdP97Smdzcpi-reau3c5reqbzNI_syt_267277I7zs6EUcMYa2zFlPfYmpPkGl47uOk399nP9lwBDg5PYUGwG-X5JlBoF5XNJqgyhznZ1rSGMCmBssXAdikC24EPmmZDJcxMCa7xD4xhGz8z6rBCfZDewggslC0QMkSF7AdoLsPiWwVNNjdqmilcXFMBGdC5MATQ5Jo4dexNZstUd_s_cI_Nq9nkh8nBpdtP8attQlI_YOP9vS-7B57r9OBp9H8WXiRlRsVEhuDawsIUca4UR9tTyCgINedacYOGSozap8iUEEoloYhVFnG0twMVPmS9EtdtnYE2Ci1EwQslAhEpiTtw4SuTaOnnxvhBn3nLJU0vG0CP1Eb1JDpCzdqkxAKpY4E-26F1b2kJjtv-UM3PUyfdae5nwgjlcy20oOB6jIarjrMsLHJTBMM-e0Zckza1ra1SSUdJIGM55D7vsxeWgiA5Ssr5OVdXdZ0efjz9D6LPJx2iV46oqJD_tHJ1FvhOBPXVodzoUKJi0Z3hdeLx5azUKaF8Shnhy-GdS76_efh5O0wPpTy-0lRXDU0iUOvHffaoEZN2ZsMhuq6JEH2WdASoM_XdkXJyYRHR0a1BTzEaPv7nPD9ht_EqqJqURxust5hfmadoVi6yAbslzyRek92ArvvvB2x1Z-_408nAHtQMrCb5BWf6fq4
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFB5qfVAQsfXS1WqPoqjQtMlkMkmEIvVSdu1F0Lb0LU4mk3ZhN1k3W0r9Uf4Yf5Hn5GYjRXzpw8KyczYkmW_OZeac8zH2PPS0lo7ilkpSaQnEkKUCB0OVJIkV14ngNhUn7-7J_oH4dOQdzbGfTS0MpVU2OrFU1EmuaY98nVoM-r4XyvDt5LtFrFF0utpQaFSw2DbnZxiyFRuDDzi_Lzjf-rj_vm_VrAKWRl97Znm-H1PhiqHWYG5qUpkoxdHPEb7nuJpzrbhBoygR6WmshFAqcIVUscfRt3OUi9e9xq6j4bVpRflHbYCHukPKujzP9Z31Gg1rkzwza3SUERJJ3gXzV7IEtLZgfjLKi8sc3b_zNS8YwK077HbtucJmBbUFNmeyRXar2vaDqpppkS3UuqKAV3VD69d32a925wL6g0OYUWOP7HgV6PAY1dkqqCyBKXnvhBIYZkD5aFDyIEHJ8QcVnVEGY5NBTS0EB7CBnzFxuBDT0hvYhLJZLlDviRwBDuiQw-wshypfHHXZCE7OqUQNaOcZHKiyWWqFbw3HTTJ9eR9oxZN8PPxhEqgT-kf4taQ5Ke6xgyuZ9ftsPsN5XGKgjUIfVPBUCUd4ykcbn9rKBNq3E2Nsp8esZoqjSdUyJCrPDX0Mtaq5iggSUQ2JHntHOGhlqeF3-UM-PY5q_REldiyMUDbXQgs6vpfoGmsZx26amNQJe2yFUBRV1bOt2oo2A8eXfsht3mPPSglq-pFRVtGxOi2KaPD58D-Evn7pCL2shdIc8ahVXcmBz0TNxDqSyx1JVF26M7xEmG_eShH9WeT4z2YdXD78tB2mi1KmYGby00omEGhXZI89qJZN-2bdEIPjQIgeCzoLqvPquyPZ8KTsuY6BE8aiXvjw3_e1wm7093d3op3B3vYjdhOfUVDhKveW2fxsemoeowc7i5-UagPYt6vWU78BFp2w5A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9RAEF5qBRFEbH3pabWjKCo0bbLZbBKhSLWWnvUNtaXf4mazaQ96ydlcKfWn-TP8Rc4km9hIEb_0w8FxOxeS7LPPzOzOC2OP40Br6SnuqCyXjkAMOSry0FXJslRxnQnuUnLy-w9ya0e83Qv2ZtjPNheGwipbTqyJOis17ZGvUonBMAxiGa_mNizi08bmy8l3hzpI0Ulr206jgci2OT1B961aG27gXD_hfPPN19dbju0w4Gi0u6dOEIYpJbEYKhPm5yaXmVIcbR4RBp6vOdeKG1SQElGfp0oIpSJfSJUGHO08T_l43UvscuijNK6lcK9z9pBHpLSpen7orVpkrEzKwqzQsUZMDfPOqMK6Y0CnF2Ynh2V1ntH7d-zmGWW4eYNdt1YsrDewm2Mzpphn15otQGgym-bZnOWNCp7Z4tbPb7Jf3S4GbA13YUpFPor9ZaCDZKS2ZVBFBkdkyRNiYFQAxaZB3RMJ6n5_0LQ2KmBsCrBthmAH1vAzpn4u1HXpBaxDXTgXqA5FiWAHNM5helJCEzuOvHYIB6eUrga0Cw0eNJEtlvyd0bgNrK_vAzV6Vo5HP0wGNrj_EL_WLU-qW2znQmb9NpstcB4XGGij0B4VPFfCE4EKUd_nrjKRDt3MGNcbMKed4mTSlA9J6jPEEN2uZq4SgkRiITFgrwgHnSwV_65_KI_2E8slSeamwgjlci20oKN8iWaylmnq55nJvXjAlghFSZNJ21FYsh55oQxj7vIBe1RLUAGQgpbSvjquqmT4cfc_hL587gk9tUJ5iXjUymZ14DNRYbGe5GJPEmlM94YXCPPtW6mSPwse_9mug_OHH3bDdFGKGixMedzIRAJ1jBywO82y6d6sH6OjHAkxYFFvQfVefX-kGB3U9dfRiUK_NIjv_vu-ltgVZKjk3fDD9j12FR9RUA4rDxbZ7PTo2NxHY3aaPqhZA9i3i6ap32A7tRo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improving+HIV+testing%2C+linkage%2C+and+retention+in+care+among+South+African+men+through+U+%3D+U+messaging%3A+A+study+protocol+for+two+sequential+hybrid+type+1+effectiveness-implementation+randomized+controlled+trials&rft.jtitle=PloS+one&rft.au=Smith%2C+Phillip&rft.au=Thirumurthy%2C+Harsha&rft.au=Medina-Marino%2C+Andrew&rft.au=Putt%2C+Mary&rft.date=2024-11-25&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=19&rft.issue=11&rft.spage=e0309905&rft_id=info:doi/10.1371%2Fjournal.pone.0309905&rft.externalDBID=n%2Fa&rft.externalDocID=A817679202
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon